Agentic discovery of blood biomarker from distilled private health records

Seffi Cohen, Liat Antwarg Friedman, Amir Anisman, Ruth Johnson, Michelle M. Li, Ayush Noori, Ben Reis, Ran Balicer and 2 others

Harvard Medical School · Clalit Research Institute · Ben-Gurion University of the Negev

Published October 3, 2026 · on the feed October 6, 2026 · ▲ 5 · arXiv 2610.04749

AgentsScience & medicine Full code arXiv ↗Hugging Face ↗

The abstract

Routine complete blood counts (CBCs) could yield new biomarkers, but the private records needed to evaluate candidates cannot be shared with frontier language model agents that excel at discovery. We distilled the evidence held in the Clalit Health Services panel of over 5.4 million patients into a released scoring tool: for each of 13 immune-mediated diseases, a graph attention network was trained inside the data boundary to predict the case-control AUC of candidate CBC expressions, and only the trained weights were released. The tool grounds an agent's propose-score-refine loop in real-world data without exposing any patient data. In external validation, agent-discovered expressions improved on their literature-seeded starting points by a median of 4.18 AUC percentage points, and across three independent cohorts, reranking the candidates of three frontier research tools improved on their first choices in most comparisons, with gains that varied by cohort. The released scorer supports privacy-preserving biomarker hypothesis generation.

The Brief

1:54

A short podcast summary of the paper. Written and voiced by AI.

Transcript

Agentic discovery of blood biomarker from distilled private health records. By Seffi Cohen and nine others, from Harvard Medical School, the Clalit Research Institute, and one other institution. Published on the third of October. Its code repository is worked out: about forty-five source files, with a readme and a licence.

Routine complete blood counts could yield new biomarkers. The obstacle is a mismatch between where the evidence sits and where the discovery tools are. The private records needed to evaluate a candidate cannot be shared with frontier language model agents, and those agents are the very tools that excel at discovery. This work releases a scoring tool that stands between the two: it carries the evidence in those records without carrying the records.

The tool covers thirteen immune-mediated diseases. For each one, a graph attention network predicts the case-control AUC of a candidate expression built from blood count values, in effect, how well that expression separates patients with the disease from controls. An agent can propose an expression, score it, and refine it, and that loop is grounded in real-world data without exposing any patient data.

The evidence comes from the Clalit Health Services panel of over five point four million patients. Each network was trained inside the data boundary, and only the trained weights were released.

In external validation, expressions discovered by an agent improved on their literature-seeded starting points by a median of four point one eight AUC percentage points. Across three independent cohorts, reranking the candidates of three frontier research tools improved on their first choices in most comparisons, with gains that varied by cohort.

It is built for anyone generating biomarker hypotheses with agents who cannot reach the underlying records. The scorer supports that work while keeping the data private.

The data never moves. What leaves the boundary is a model of what the data would say about a candidate, and the agent searches against that model instead of the records. Privacy and discovery stop competing for the same access.

More with an account

Listen to every day’s papers

Daily playlists, deep dives, quests for the papers, and quizzes on their key terms.

Join free
KipQuest: the day’s AI research, as podcasts and quests. All papers Android app Privacy Contact Episodes are written and voiced by AI from each paper. Summaries can contain mistakes: the paper is the source.